S

SICAR

Description

SICAR

Investor Profile

SICAR has made 2 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • United States (50%)
  • Germany (50%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SICAR frequently co-invest with?

RV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
SMS Group
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
Bio Capital Impact Fund
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
KG Investments
North America, Arizona, United States, Scottsdale
Co-Investments: 1
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by SICAR?

OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series CNov 2, 2018
Amount Raised: $19,357,777
Fore Biotherapeutics

Philadelphia, Pennsylvania, United States

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology
Series UnknownApr 30, 2018
Amount Raised: $6,000,000